A simple method to cure established tumors by inflammatory killing of normal cells

Gregory A. Daniels, Luis Sanchez-Perez, Rosa Maria Diaz, Timothy Kottke, Jill Thompson, Maoyi Lai, Michael Gough, Mahzuz Karim, Andrew Bushell, Heung Chong, Alan Melcher, Kevin Harrington, Richard Geoffrey Vile

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

We describe a simple technology used to cure an established metastatic disease. Intradermal injection of plasmid DNA encoding a transcriptionally targeted cytotoxic gene, along with hsp70, not only promoted tissue-specific, inflammatory killing of normal melanocytes, but also induced a CD8+ T-cell-dependent, antigen-specific response in mice that eradicated systemically established B16 tumors. This CD8+ T cell response was subsequently suppressed in vivo within a few days. The data demonstrate that deliberate destruction of normal tissue can be exploited to generate immunity against a malignant disease originating from that tissue. This approach obviates the need to identify tumor antigens and does not require complex isolation of tumor cells or their derivatives. In addition, it provides a model system for studying the mechanisms underlying the etiology and control of autoimmune diseases. Finally, despite targeting normal tissue, therapy could be separated from development of overt autoimmune symptoms, suggesting that the strategy may be valuable against tumors derived from both non-essential and essential tissue types.

Original languageEnglish (US)
Pages (from-to)1125-1132
Number of pages8
JournalNature Biotechnology
Volume22
Issue number9
DOIs
StatePublished - Sep 2004

Fingerprint

Tumors
Cells
Tissue
T-cells
Neoplasms
Antigens
T-Lymphocytes
Intradermal Injections
Cell Separation
Melanocytes
Neoplasm Antigens
Cell- and Tissue-Based Therapy
Autoimmune Diseases
Immunity
Plasmids
Technology
DNA
Genes
Derivatives

ASJC Scopus subject areas

  • Microbiology

Cite this

Daniels, G. A., Sanchez-Perez, L., Diaz, R. M., Kottke, T., Thompson, J., Lai, M., ... Vile, R. G. (2004). A simple method to cure established tumors by inflammatory killing of normal cells. Nature Biotechnology, 22(9), 1125-1132. https://doi.org/10.1038/nbt1007

A simple method to cure established tumors by inflammatory killing of normal cells. / Daniels, Gregory A.; Sanchez-Perez, Luis; Diaz, Rosa Maria; Kottke, Timothy; Thompson, Jill; Lai, Maoyi; Gough, Michael; Karim, Mahzuz; Bushell, Andrew; Chong, Heung; Melcher, Alan; Harrington, Kevin; Vile, Richard Geoffrey.

In: Nature Biotechnology, Vol. 22, No. 9, 09.2004, p. 1125-1132.

Research output: Contribution to journalArticle

Daniels, GA, Sanchez-Perez, L, Diaz, RM, Kottke, T, Thompson, J, Lai, M, Gough, M, Karim, M, Bushell, A, Chong, H, Melcher, A, Harrington, K & Vile, RG 2004, 'A simple method to cure established tumors by inflammatory killing of normal cells', Nature Biotechnology, vol. 22, no. 9, pp. 1125-1132. https://doi.org/10.1038/nbt1007
Daniels GA, Sanchez-Perez L, Diaz RM, Kottke T, Thompson J, Lai M et al. A simple method to cure established tumors by inflammatory killing of normal cells. Nature Biotechnology. 2004 Sep;22(9):1125-1132. https://doi.org/10.1038/nbt1007
Daniels, Gregory A. ; Sanchez-Perez, Luis ; Diaz, Rosa Maria ; Kottke, Timothy ; Thompson, Jill ; Lai, Maoyi ; Gough, Michael ; Karim, Mahzuz ; Bushell, Andrew ; Chong, Heung ; Melcher, Alan ; Harrington, Kevin ; Vile, Richard Geoffrey. / A simple method to cure established tumors by inflammatory killing of normal cells. In: Nature Biotechnology. 2004 ; Vol. 22, No. 9. pp. 1125-1132.
@article{89de474758c4434691a99f912a2319dc,
title = "A simple method to cure established tumors by inflammatory killing of normal cells",
abstract = "We describe a simple technology used to cure an established metastatic disease. Intradermal injection of plasmid DNA encoding a transcriptionally targeted cytotoxic gene, along with hsp70, not only promoted tissue-specific, inflammatory killing of normal melanocytes, but also induced a CD8+ T-cell-dependent, antigen-specific response in mice that eradicated systemically established B16 tumors. This CD8+ T cell response was subsequently suppressed in vivo within a few days. The data demonstrate that deliberate destruction of normal tissue can be exploited to generate immunity against a malignant disease originating from that tissue. This approach obviates the need to identify tumor antigens and does not require complex isolation of tumor cells or their derivatives. In addition, it provides a model system for studying the mechanisms underlying the etiology and control of autoimmune diseases. Finally, despite targeting normal tissue, therapy could be separated from development of overt autoimmune symptoms, suggesting that the strategy may be valuable against tumors derived from both non-essential and essential tissue types.",
author = "Daniels, {Gregory A.} and Luis Sanchez-Perez and Diaz, {Rosa Maria} and Timothy Kottke and Jill Thompson and Maoyi Lai and Michael Gough and Mahzuz Karim and Andrew Bushell and Heung Chong and Alan Melcher and Kevin Harrington and Vile, {Richard Geoffrey}",
year = "2004",
month = "9",
doi = "10.1038/nbt1007",
language = "English (US)",
volume = "22",
pages = "1125--1132",
journal = "Biotechnology",
issn = "1087-0156",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - A simple method to cure established tumors by inflammatory killing of normal cells

AU - Daniels, Gregory A.

AU - Sanchez-Perez, Luis

AU - Diaz, Rosa Maria

AU - Kottke, Timothy

AU - Thompson, Jill

AU - Lai, Maoyi

AU - Gough, Michael

AU - Karim, Mahzuz

AU - Bushell, Andrew

AU - Chong, Heung

AU - Melcher, Alan

AU - Harrington, Kevin

AU - Vile, Richard Geoffrey

PY - 2004/9

Y1 - 2004/9

N2 - We describe a simple technology used to cure an established metastatic disease. Intradermal injection of plasmid DNA encoding a transcriptionally targeted cytotoxic gene, along with hsp70, not only promoted tissue-specific, inflammatory killing of normal melanocytes, but also induced a CD8+ T-cell-dependent, antigen-specific response in mice that eradicated systemically established B16 tumors. This CD8+ T cell response was subsequently suppressed in vivo within a few days. The data demonstrate that deliberate destruction of normal tissue can be exploited to generate immunity against a malignant disease originating from that tissue. This approach obviates the need to identify tumor antigens and does not require complex isolation of tumor cells or their derivatives. In addition, it provides a model system for studying the mechanisms underlying the etiology and control of autoimmune diseases. Finally, despite targeting normal tissue, therapy could be separated from development of overt autoimmune symptoms, suggesting that the strategy may be valuable against tumors derived from both non-essential and essential tissue types.

AB - We describe a simple technology used to cure an established metastatic disease. Intradermal injection of plasmid DNA encoding a transcriptionally targeted cytotoxic gene, along with hsp70, not only promoted tissue-specific, inflammatory killing of normal melanocytes, but also induced a CD8+ T-cell-dependent, antigen-specific response in mice that eradicated systemically established B16 tumors. This CD8+ T cell response was subsequently suppressed in vivo within a few days. The data demonstrate that deliberate destruction of normal tissue can be exploited to generate immunity against a malignant disease originating from that tissue. This approach obviates the need to identify tumor antigens and does not require complex isolation of tumor cells or their derivatives. In addition, it provides a model system for studying the mechanisms underlying the etiology and control of autoimmune diseases. Finally, despite targeting normal tissue, therapy could be separated from development of overt autoimmune symptoms, suggesting that the strategy may be valuable against tumors derived from both non-essential and essential tissue types.

UR - http://www.scopus.com/inward/record.url?scp=4444345447&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4444345447&partnerID=8YFLogxK

U2 - 10.1038/nbt1007

DO - 10.1038/nbt1007

M3 - Article

C2 - 15300260

AN - SCOPUS:4444345447

VL - 22

SP - 1125

EP - 1132

JO - Biotechnology

JF - Biotechnology

SN - 1087-0156

IS - 9

ER -